ELMS STEVE
SEC Form 4 insider trading activity
ELMS STEVE has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Mar 9, 2026.
On the most recent filing, ELMS STEVE is listed as Director at ADMA BIOLOGICS, INC. Inside the rolling window, ELMS STEVE reported 2 open-market purchases totaling $217K in ADMA and no open-market sales. The largest disclosed transaction in the window is a purchase of 7,000 ADMA shares on Mar 5, 2026, worth $110K.
Companies traded
Other insiders at ADMA
Insider Buying
$217K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has ELMS STEVE made?
ELMS STEVE has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company since 2026.
Which companies does ELMS STEVE trade?
ELMS STEVE has filed SEC Form 4 disclosures for 1 company, including ADMA.
When was ELMS STEVE's most recent SEC Form 4 filing?
ELMS STEVE's most recent SEC Form 4 filing on Tracefour is dated Mar 9, 2026.
What is ELMS STEVE's total buy and sell value in the current window?
Inside the rolling retention window, ELMS STEVE bought $217K and sold $0 based on SEC Form 4 filings.
What was ELMS STEVE's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 7,000 ADMA shares on 2026-03-05, worth $110K, per SEC Form 4 filings.